Brain Metastasis from Non-Small Cell Lung Cancer: Use of Epidermal Growth Factor Receptor and HER2 Status for Targeted Therapy

Medicine and Dentistry

• Brain Metastasis 100%
• Non Small Cell Lung Cancer 75%
• Targeted Therapy 75%
• Combination Therapy 50%
• Epidermal Growth Factor Receptor 50%
• Metastatic Carcinoma 25%
• Therapeutic Agent 25%
• Morbidity 25%
• Lung Carcinoma 25%
• Mortality 25%
• Brain 25%
• Tissues 25%
• Patient 25%
• Therapeutic Procedure 25%
• Inpatient 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Brain Metastasis 100%
• Non Small Cell Lung Cancer 75%
• Epidermal Growth Factor Receptor 50%
• Metastasis 25%
• Morbidity 25%
• Lung Carcinoma 25%
• Mortality 25%